<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Proteostatic Failure and Propagation Theory of Alzheimer's Disease - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Theory Details for theory-2363</h1>

        <div class="section">
            <h2>Theory (General Information)</h2>
            <div class="info-section">
                <p><strong>ID:</strong> theory-2363</p>
                <p><strong>Name:</strong> Proteostatic Failure and Propagation Theory of Alzheimer's Disease</p>
                <p><strong>Type:</strong> general</p>
                <p><strong>Theory Query:</strong> Build a theory of the causes of Alzheimer's disease and effective detection methods.</p>
                <p><strong>Description:</strong> This theory proposes that Alzheimer's disease is fundamentally a disorder of proteostasis, where the failure of protein quality control systems (e.g., autophagy, ubiquitin-proteasome system) leads to the accumulation and propagation of misfolded proteins (amyloid-beta, tau) in a prion-like manner. The spread of these aggregates through neural circuits drives neurodegeneration. Early detection is possible by identifying peripheral or central markers of proteostatic stress and misfolded protein seeds.</p>
                <p><strong>Knowledge Cutoff Year:</strong> -1</p>
                <p><strong>Knowledge Cutoff Month:</strong> -1</p>
            </div>
        </div>

        <div class="section">
            <h2>Theory (Derived From)</h2>
            <p><strong>Derived From:</strong> <span class="empty-note">None</span></p>
            <p><strong>Change Log:</strong> <span class="empty-note">No change log entries.</span></p>
        </div>

        <div class="section">
            <h2>Evaluations of this Theory</h2>
            <p class="empty-note">No evaluations of this theory.</p>
        </div>

        <div class="section">
            <h2>Theory (Details)</h2>

            <h3>Theory Statements</h3>
            <h3>Statement 0: Proteostatic Collapse Law (qualitative)</h3>
<table>
<thead> 
<tr><th style="width: 10%;">Condition</th><th style="width: 90%;">Details</th></tr>
</thead>
<tbody>
<tr>
    <td><strong>IF</strong></td>
    <td>
        <div>&#8226; individual &#8594; exhibits &#8594; impaired protein quality control (e.g., reduced autophagy, proteasome activity)</div>
    </td>
</tr>
<tr>
    <td><strong>THEN</strong></td>
    <td>
        <div>&#8226; individual &#8594; accumulates &#8594; misfolded amyloid-beta and tau proteins</div>
    </td>
</tr>
</tbody>
</table>
            <h4>Supporting Evidence for this Law</h4>
<ol>
    <li>AD brains show reduced autophagy and proteasome activity. </li>
    <li>Genetic or pharmacological impairment of proteostasis in animal models accelerates amyloid and tau pathology. </li>
</ol>            <h4>Existing Law Comparison</h4>
            <p><strong>Likely Classification:</strong> <span style="color: orange; font-weight: bold;">somewhat-related-to-existing</span></p>
            <p><strong>Explanation:</strong> The centrality of proteostatic collapse is a novel theoretical emphasis.</p>            <p><strong>What Already Exists:</strong> Proteostasis impairment is recognized in AD, but not as the central, initiating event.</p>            <p><strong>What is Novel:</strong> This law elevates proteostatic failure as the primary cause of misfolded protein accumulation.</p>
            <p><strong>References:</strong> <ul>
    <li>Ciechanover & Kwon (2015) Proteostasis and the ubiquitin-proteasome system in neurodegeneration [Proteostasis in AD]</li>
    <li>Hara et al. (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice [Autophagy and neurodegeneration]</li>
</ul>
            <h3>Statement 1: Prion-like Propagation Law (qualitative)</h3>
<table>
<thead> 
<tr><th style="width: 10%;">Condition</th><th style="width: 90%;">Details</th></tr>
</thead>
<tbody>
<tr>
    <td><strong>IF</strong></td>
    <td>
        <div>&#8226; misfolded protein seeds &#8594; are present in &#8594; neural tissue</div>
    </td>
</tr>
<tr>
    <td><strong>THEN</strong></td>
    <td>
        <div>&#8226; misfolded protein seeds &#8594; induce &#8594; spread of pathology along neural circuits</div>
    </td>
</tr>
</tbody>
</table>
            <h4>Supporting Evidence for this Law</h4>
<ol>
    <li>Experimental injection of misfolded tau or amyloid-beta seeds induces spread of pathology in animal models. </li>
    <li>Human AD brains show stereotyped progression of tau pathology along neural networks. </li>
</ol>            <h4>Existing Law Comparison</h4>
            <p><strong>Likely Classification:</strong> closely-related-to-existing</p>
            <p><strong>Explanation:</strong> The prion-like propagation model is emerging but not yet universally formalized as a law.</p>            <p><strong>What Already Exists:</strong> Prion-like propagation of tau and amyloid is increasingly recognized.</p>            <p><strong>What is Novel:</strong> This law formalizes prion-like spread as a core mechanism of AD progression.</p>
            <p><strong>References:</strong> <ul>
    <li>Jucker & Walker (2013) Self-propagation of pathogenic protein aggregates in neurodegenerative diseases [Prion-like spread]</li>
    <li>Braak & Braak (1991) Neuropathological stageing of Alzheimer-related changes [Stereotyped progression]</li>
</ul>
            <h3>New Predictions (Likely outcome)</h3>
            <ol>
                <li>Early markers of proteostatic stress (e.g., increased ubiquitinated proteins in CSF or blood) will predict AD risk.</li>
                <li>Interventions that enhance autophagy or proteasome activity will slow or prevent AD pathology.</li>
            </ol>
            <h3>New Predictions (Unknown outcome/high-entropy)</h3>
            <ol>
                <li>Peripheral detection of misfolded protein seeds will enable preclinical AD diagnosis.</li>
                <li>Blocking prion-like propagation will halt disease progression even after pathology has begun.</li>
            </ol>
            <h3>Negative Experiments</h3>
            <ol>
                <li>If proteostatic impairment does not precede amyloid/tau accumulation, the theory is challenged.</li>
                <li>If blocking prion-like propagation does not slow disease, the theory is called into question.</li>
            </ol>
            <h3>Unaccounted for Evidence</h3>
<ol>
    <li>Some AD cases show minimal amyloid or tau pathology. </li>
</ol>            <h3>Existing Theory Comparison</h3>
            <p><strong>Likely Classification:</strong> closely-related-to-existing</p>
            <p><strong>Explanation:</strong> This theory synthesizes and formalizes emerging concepts into a unified, central framework.</p>
            <p><strong>References:</strong> <ul>
    <li>Ciechanover & Kwon (2015) Proteostasis and the ubiquitin-proteasome system in neurodegeneration [Proteostasis in AD]</li>
    <li>Jucker & Walker (2013) Self-propagation of pathogenic protein aggregates in neurodegenerative diseases [Prion-like spread]</li>
</ul>
        </div>

        <div class="section">
            <h2>Theory Components (Debug)</h2>
            <pre><code>{
    "theory_name": "Proteostatic Failure and Propagation Theory of Alzheimer's Disease",
    "theory_description": "This theory proposes that Alzheimer's disease is fundamentally a disorder of proteostasis, where the failure of protein quality control systems (e.g., autophagy, ubiquitin-proteasome system) leads to the accumulation and propagation of misfolded proteins (amyloid-beta, tau) in a prion-like manner. The spread of these aggregates through neural circuits drives neurodegeneration. Early detection is possible by identifying peripheral or central markers of proteostatic stress and misfolded protein seeds.",
    "theory_statements": [
        {
            "law": {
                "law_name": "Proteostatic Collapse Law",
                "if": [
                    {
                        "subject": "individual",
                        "relation": "exhibits",
                        "object": "impaired protein quality control (e.g., reduced autophagy, proteasome activity)"
                    }
                ],
                "then": [
                    {
                        "subject": "individual",
                        "relation": "accumulates",
                        "object": "misfolded amyloid-beta and tau proteins"
                    }
                ],
                "supporting_evidence": [
                    {
                        "text": "AD brains show reduced autophagy and proteasome activity.",
                        "uuids": []
                    },
                    {
                        "text": "Genetic or pharmacological impairment of proteostasis in animal models accelerates amyloid and tau pathology.",
                        "uuids": []
                    }
                ],
                "qual_or_quant": "qualitative",
                "existing_law": {
                    "what_already_exists": "Proteostasis impairment is recognized in AD, but not as the central, initiating event.",
                    "what_is_novel": "This law elevates proteostatic failure as the primary cause of misfolded protein accumulation.",
                    "classification_explanation": "The centrality of proteostatic collapse is a novel theoretical emphasis.",
                    "likely_classification": "somewhat-related-to-existing",
                    "references": [
                        "Ciechanover & Kwon (2015) Proteostasis and the ubiquitin-proteasome system in neurodegeneration [Proteostasis in AD]",
                        "Hara et al. (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice [Autophagy and neurodegeneration]"
                    ]
                }
            }
        },
        {
            "law": {
                "law_name": "Prion-like Propagation Law",
                "if": [
                    {
                        "subject": "misfolded protein seeds",
                        "relation": "are present in",
                        "object": "neural tissue"
                    }
                ],
                "then": [
                    {
                        "subject": "misfolded protein seeds",
                        "relation": "induce",
                        "object": "spread of pathology along neural circuits"
                    }
                ],
                "supporting_evidence": [
                    {
                        "text": "Experimental injection of misfolded tau or amyloid-beta seeds induces spread of pathology in animal models.",
                        "uuids": []
                    },
                    {
                        "text": "Human AD brains show stereotyped progression of tau pathology along neural networks.",
                        "uuids": []
                    }
                ],
                "qual_or_quant": "qualitative",
                "existing_law": {
                    "what_already_exists": "Prion-like propagation of tau and amyloid is increasingly recognized.",
                    "what_is_novel": "This law formalizes prion-like spread as a core mechanism of AD progression.",
                    "classification_explanation": "The prion-like propagation model is emerging but not yet universally formalized as a law.",
                    "likely_classification": "closely-related-to-existing",
                    "references": [
                        "Jucker & Walker (2013) Self-propagation of pathogenic protein aggregates in neurodegenerative diseases [Prion-like spread]",
                        "Braak & Braak (1991) Neuropathological stageing of Alzheimer-related changes [Stereotyped progression]"
                    ]
                }
            }
        }
    ],
    "new_predictions_likely": [
        "Early markers of proteostatic stress (e.g., increased ubiquitinated proteins in CSF or blood) will predict AD risk.",
        "Interventions that enhance autophagy or proteasome activity will slow or prevent AD pathology."
    ],
    "new_predictions_unknown": [
        "Peripheral detection of misfolded protein seeds will enable preclinical AD diagnosis.",
        "Blocking prion-like propagation will halt disease progression even after pathology has begun."
    ],
    "negative_experiments": [
        "If proteostatic impairment does not precede amyloid/tau accumulation, the theory is challenged.",
        "If blocking prion-like propagation does not slow disease, the theory is called into question."
    ],
    "unaccounted_for": [
        {
            "text": "Some AD cases show minimal amyloid or tau pathology.",
            "uuids": []
        }
    ],
    "conflicting_evidence": [
        {
            "text": "Individuals with proteostatic impairment may not always develop AD.",
            "uuids": []
        }
    ],
    "special_cases": [
        "Genetic forms of AD with overproduction of amyloid may bypass proteostatic failure.",
        "Co-pathologies (e.g., TDP-43, alpha-synuclein) may complicate detection and progression."
    ],
    "existing_theory": {
        "what_already_exists": "Proteostasis and prion-like propagation are recognized in AD, but not always as central, unifying mechanisms.",
        "what_is_novel": "The elevation of proteostatic failure and propagation as the primary, unifying cause is novel.",
        "classification_explanation": "This theory synthesizes and formalizes emerging concepts into a unified, central framework.",
        "likely_classification": "closely-related-to-existing",
        "references": [
            "Ciechanover & Kwon (2015) Proteostasis and the ubiquitin-proteasome system in neurodegeneration [Proteostasis in AD]",
            "Jucker & Walker (2013) Self-propagation of pathogenic protein aggregates in neurodegenerative diseases [Prion-like spread]"
        ]
    },
    "reflected_from_theory_index": 3,
    "type": "general",
    "version": "built-theory-from-results-single-theory-reflection2-nov14-2025-LLM-BASELINE-no-evidence-without-matched-control-theory-name",
    "theory_query": "Build a theory of the causes of Alzheimer's disease and effective detection methods.",
    "original_theory_id": "theory-683",
    "original_theory_name": "Peripheral Platelet Tau/AÎ² Signature as a Surrogate for Central Neurodegeneration",
    "provide_matched_control_thery_name": false,
    "matched_control_theory_name": null,
    "model_str": "openai/gpt-4.1-2025-04-14"
}</code></pre>
        </div>
    </div>
</body>
</html>